| Indicators | Browse All

DBV Technologies S.A. (DBVT)

Healthcare | Biotechnology | Châtillon, France | NasdaqCM
15.98 USD -0.51 (-3.093%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4:25 a.m. EDT

The stock presents a classic biotech value trap where a massive analyst price target and recent price recovery mask deteriorating fundamentals. While the price has surged nearly 1,200% year-over-year, this is driven by a specific clinical milestone (VIASKIN filing) rather than sustainable business growth, evidenced by nine consecutive years of negative revenue growth prior to this spike and a trailing twelve-month loss of 78%. The balance sheet is fragile, with operating cash flow burning at -$150 million and negative free cash flow, while the company trades at a premium valuation relative to sales despite having no earnings. For the short term, the recent volatility and lack of a clear trend suggest a neutral stance, but the long-term outlook is severely compromised by the inability to generate consistent revenue or profits, making it a poor candidate for buy-and-hold strategies.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.150389
AutoETS0.152103
AutoARIMA0.314326
AutoTheta0.318575

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 25%
H-stat 18.25
Ljung-Box p 0.000
Jarque-Bera p 0.152
Excess Kurtosis -1.41
Attribute Value
Sector Healthcare
Debt to Equity Ratio 2.934
Revenue per Share 0.13
Market Cap 945,803,264
Forward P/E -32.44
Beta -0.21
Website https://www.dbv-technologies.com

Info Dump

Attribute Value
52 Week Change 0.613503
Address1 BAtiment IRO
Address2 107 Av. de la REpublique
All Time High 101.14
All Time Low 0.441
Ask 16.12
Ask Size 1
Average Analyst Rating 1.8 - Buy
Average Daily Volume10 Day 234,280
Average Daily Volume3 Month 251,791
Average Volume 251,791
Average Volume10Days 234,280
Beta -0.212
Bid 15.91
Bid Size 2
Book Value 3.515
City Châtillon
Compensation As Of Epoch Date 1,767,139,200
Country France
Crypto Tradeable 0
Currency USD
Current Price 15.98
Current Ratio 4.763
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 16.4791
Day Low 15.63
Debt To Equity 2.934
Display Name DBV
Earnings Call Timestamp End 1,722,375,000
Earnings Call Timestamp Start 1,722,375,000
Earnings Timestamp 1,785,355,200
Earnings Timestamp End 1,785,355,200
Earnings Timestamp Start 1,785,355,200
Ebitda -165,162,000
Ebitda Margins 0.0
Enterprise To Ebitda -4.375
Enterprise To Revenue 125.984
Enterprise Value 722,642,368
Eps Current Year -0.45525
Eps Forward -0.49264848
Eps Trailing Twelve Months -4.5
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 17.7995
Fifty Day Average Change -1.8195
Fifty Day Average Change Percent -0.10222197
Fifty Two Week Change Percent 61.350296
Fifty Two Week High 26.185
Fifty Two Week High Change -10.205
Fifty Two Week High Change Percent -0.38972694
Fifty Two Week Low 8.51
Fifty Two Week Low Change 7.4699993
Fifty Two Week Low Change Percent 0.87779075
Fifty Two Week Range 8.51 - 26.185
Financial Currency USD
First Trade Date Milliseconds 1,413,984,600,000
Float Shares 35,254,055
Forward Eps -0.49264848
Forward P E -32.43692
Free Cashflow -87,206,000
Full Exchange Name NasdaqCM
Full Time Employees 161
Gmt Off Set Milliseconds -14,400,000
Gross Margins 1.0
Gross Profits 5,736,000
Has Pre Post Market Data 1
Held Percent Insiders 0.0
Held Percent Institutions 0.37248
Implied Shares Outstanding 59,186,686
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,717,718,400
Last Split Factor 1:2
Long Business Summary DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Long Name DBV Technologies S.A.
Market us_market
Market Cap 945,803,264
Market State PRE
Max Age 86,400
Message Board Id finmb_7406282
Most Recent Quarter 1,774,915,200
Net Income To Common -167,447,008
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 961,149,982
Number Of Analyst Opinions 6
Open 16.17
Operating Cashflow -150,580,992
Operating Margins -53.111107
Payout Ratio 0.0
Phone 33 1 55 42 78 78
Previous Close 16.49
Price Eps Current Year -35.101593
Price Hint 2
Price To Book 4.5462303
Price To Sales Trailing12 Months 164.88899
Profit Margins 0.0
Quick Ratio 4.716
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.83333
Region US
Regular Market Change -0.51
Regular Market Change Percent -3.09278
Regular Market Day High 16.4791
Regular Market Day Low 15.63
Regular Market Day Range 15.63 - 16.4791
Regular Market Open 16.17
Regular Market Previous Close 16.49
Regular Market Price 15.98
Regular Market Time 1,783,972,801
Regular Market Volume 129,514
Return On Assets -0.66355
Return On Equity -1.5888801
Revenue Growth 0.125
Revenue Per Share 0.13
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 59,186,686
Shares Percent Shares Out 0.022
Shares Short 1,299,136
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 1,666,927
Short Name DBV Technologies S.A.
Short Percent Of Float 0.022
Short Ratio 4.18
Source Interval 15
Symbol DBVT
Target High Price 54.943527
Target Low Price 5.818597
Target Mean Price 40.675037
Target Median Price 46.93554
Total Cash 229,200,000
Total Cash Per Share 3.873
Total Debt 6,100,000
Total Revenue 5,736,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.5
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 18.06964
Two Hundred Day Average Change -2.0896397
Two Hundred Day Average Change Percent -0.11564369
Type Disp Equity
Volume 129,514
Website https://www.dbv-technologies.com
Zip 92,320